Ahmad Shadid, founder of O.XYZ, examines the rise of “vibe coding” and what it means for the future of software development. More than a productivity shift, Shadid argues that vibe coding is a ...
Custom programs are designed to fit your needs — regardless of what stage your organization is in. If you're in a leadership ...
Thinking like a developer, and leading with those same principles, can help organizations move faster, stay aligned and build ...
Can $200 buy years of productivity? My latest AI experiment turned side projects into full products almost overnight, and the possibilities suddenly seem endless.
The Panama City Downtown Improvement Board is considering a new program to incentivize more development downtown. It’s a tax increment financing or TIF program. It uses potential property tax ...
The Business & Financial Times on MSN
Your environmental spotlight with Edna Obiri: The Montreal Protocol: A Template for Climate Action Success
In 1987, the world came together to sign the Montreal Protocol, an agreement designed to phase out substances that were ‘eating away’ the Earth’s ozone layer.Almost four decades later, it remains the ...
Two public information sessions are scheduled to share the Jeannette Initiative’s plans for revitalization as the ...
I spent almost two years after I left the Cyber Protection Brigade working on training. Not traditional military training like ranges, land ...
CAMBRIDGE, Mass., August 27, 2025--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) ("Amylyx" or the "Company") today announced the decision to discontinue the ORION program of AMX0035 ...
SCHENECTADY, N.Y. — A new state grant is set to enhance access to early childhood development tools for families in Schenectady. Assemblymember Phil Steck presented a $25,000 check to Ellis Medicine ...
UAB Medicine’s Leadership Development Office welcomed 18 individuals in its 11th cohort of Institute for Leadership in August 2025. UAB Medicine Institute for Leadership is a flagship program of the ...
Celldex has stopped development of barzolvolimab in eosinophilic esophagitis (EoE) despite meeting its primary endpoint in a phase 2 trial. The biotech showed the candidate depletes mast cells in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results